The initial comparison of HSPB2 mRNA levels among 16 pairs of malignant breast tumors and their adjacent non-cancerous breast tissues revealed the downregulation of the HSPB2 mRNA expression in the majority of malignant breast tumors (p < 0.001) (Figure 2). This evidence concerns the gene HSPB2 and breast cancer.